1 February 1988 in European Journal of Pharmacology
5 July 2016 in Environmental Toxicology
EAEbunoluwa Racheal Asenuga
Ebunoluwa Racheal Asenuga
AAAbiola Olumuyiwa Adejumobi
Abiola Olumuyiwa Adejumobi
TATemitayo Olabisi Ajibade
+3
1 September 2018 in BioFactors
TOTemidayo Olutayo Omobowale
Temidayo Olutayo Omobowale
OOOlufunke Eunice Ola‐Davies
Olufunke Eunice Ola‐Davies
EAEbunoluwa Racheal Asenuga
Ebunoluwa Racheal Asenuga
TATemitayo Olabisi Ajibade
+9
1 May 1995 in American Journal of Physiology-Heart and Circulatory Physiology
Effects of the lipid mediator lysophosphatidic acid (LPA) were studied on the cerebral circulation of newborn pigs using closed cranial windows. Topical application of synthetic LPA caused dose-dependent vasoconstriction and inhibited vasodilation to hypercapnia and isoproterenol. These vasodilators elicited a rise in the adenosine 3',5'-cyclic monophosphate (cAMP) content of the cerebrospinal fluid, which was inhibited dose dependently by LPA. Pertussis toxin (1 microgram/ml) completely abolished LPA-induced vasoconstriction and the altered vascular reactivity, and LPA no longer decreased cAMP. Electrophysiological recording of currents evoked by LPA-like lipids in Xenopus oocytes showed that cerebrospinal fluid is normally devoid of LPA-like factors. In contrast, the amount of LPA-like factors generated 4 days after intrathecal injection of autologous blood was in the range of 1-10 microM LPA equivalents. The data indicate that LPA-like bioactive mediators were generated in an intracranial hematoma model and that these phospholipids might play a role in the pathophysiology of altered vascular reactivity often found in posthemorrhagic conditions and could also contribute to the development of posthemorrhagic vasoconstriction.
26 November 2018 in BioFactors
OOOlufunke Eunice Ola‐Davies
Olufunke Eunice Ola‐Davies
EAEbunoluwa Racheal Asenuga
Ebunoluwa Racheal Asenuga
TATemitayo Olabisi Ajibade
+6
1 July 1994 in Molecular and Biochemical Parasitology